The North America Automated And Closed Cell Therapy Processing Systems Market is expected to witness market growth of 19.6% CAGR during the forecast period (2021-2027).
Automated process system as a sustainable strategy to boost their cell therapy product development procedure, which is expected to propel the growth of the market. There has been an increase in clinical trials regarding advanced therapies in the past few years, which is estimated to surge the demand for advanced & automated technologies to get high yield and throughput.
The strong healthcare sector of developed nations like the US and Canada is estimated to support the growth of the regional market. In addition, the high adoption of various advanced systems, therapies, and solutions in the regional healthcare sector is estimated to support the growth of the regional automated and closed cell therapy processing system market in the upcoming years. Along with that, the growing popularity of regenerative medicines and stem cell therapies is expected to accelerate the growth of the regional market over the forecast period.
The US market dominated the North America Automated and Closed Cell Therapy Processing Systems Market by Country in 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $709.8 million by 2027. The Canada market is estimated to grow a CAGR of 22.3% during (2021 - 2027). Additionally, The Mexico market is expected to showcase a CAGR of 21.2% during (2021 - 2027).
Based on type, the market is segmented into stem cell therapy, and non-stem cell therapy. Based on workflow, the market is segmented into separation, expansion, apheresis, fill-finish, cryopreservation and others. Based on scale, the market is segmented into Pre-commercial/R&D Scale and Commercial Scale.Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Lonza Group AG, Terumo Corporation, Cytiva (Danaher Corporation), Thermo Fisher Scientific, Inc., Miltenyi Biotec B.V. & Co. KG, Thermogenesis Holdings, Inc., Cellares Inc., Biospherix ltd., Sartorius AG, and Fresenius SE & Co. KGaA.
Scope of the Study
Market Segments Covered in the Report:
By Type
- Separation
- Expansion
- Apheresis
- Fill-Finish
- Cryopreservation
By Workflow
- Stem Cell Therapy
- Non-Stem Cell Therapy
By Scale
- Pre-commercial/R&D Scale
- Commercial Scale
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Lonza Group AG
- Terumo Corporation
- Cytiva (Danaher Corporation)
- Thermo Fisher Scientific, Inc.
- Miltenyi Biotec B.V. & Co. KG
- Thermogenesis Holdings, Inc.
- Cellares Inc.
- Biospherix ltd.
- Sartorius AG
- Fresenius SE & Co. KGaA
Unique Offerings from the Publisher
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Companies Mentioned
- Lonza Group AG
- Terumo Corporation
- Cytiva (Danaher Corporation)
- Thermo Fisher Scientific, Inc.
- Miltenyi Biotec B.V. & Co. KG
- Thermogenesis Holdings, Inc.
- Cellares Inc.
- Biospherix ltd.
- Sartorius AG
- Fresenius SE & Co. KGaA
Methodology
LOADING...
